Trine has + 20 years’ experience in the life science sector, working in her favorite place being the intersection between Life Science and Business. She is part of the Executive Leadership Team, leading the Venture Creation Department. The Team is responsible for Scouting, Sourcing, Due Diligence and providing Acceleration expertise to start ups and scientific projects. Furthermore, her Team runs the company creation program, Bio Studio, as well as selective Centers of Excellence to drive innovation in specific areas of high unmet needs, including Women’s Health, Brain Health and Bio Solutions.
Prior to joining BII, Trine worked as an Investment Director at Sunstone Life Science Ventures, investing in health tech and pharmaceuticals. Furthermore, she spent 6 years with Novo Nordisk working with the strategic planning of the R&D portfolio within metabolic diseases/obesity followed by initiating Novo Nordisk’s Digital Health journey. Also, she has served as a CEO in two clinical organizations within Women’s Health. She holds a M.Sc. in Finance and Accounting (Copenhagen Business School) and a Certificate in Pharmaceutical Drug Development from European Center of Pharmaceutical Medicine (ECPM, Basel).
BioInnovation Institute is a non-profit life science institute bridging the gap between academia and business, working with accelerator and incubator models. Established in 2018 by the Novo Nordisk Foundation, it has to date fostered +112 life science start-ups within pharmaceuticals, health tech and bio industrials.